Loading…

Prophylactic effect of Biochanin A in lipopolysaccharide-stimulated BV2 microglial cells

Aim/Purpose of the study:Inhibition of microglial activation using phytochemicals may be a potential candidate for the prevention of neurodegenerative diseases caused by neuroinflammation and oxidative stress. The goal of this study was to investigate the protective role of Biochanin A on lipopolysa...

Full description

Saved in:
Bibliographic Details
Published in:Immunopharmacology and immunotoxicology 2020-07, Vol.42 (4), p.330-339
Main Authors: Berköz, Mehmet, Krośniak, Mirosław, Özkan-Yılmaz, Ferbal, Özlüer-Hunt, Arzu
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c366t-2da095b8c43379e31612d9aeb7337a5f7568c6dcc5c2a9301ee5fb9b052450f3
cites cdi_FETCH-LOGICAL-c366t-2da095b8c43379e31612d9aeb7337a5f7568c6dcc5c2a9301ee5fb9b052450f3
container_end_page 339
container_issue 4
container_start_page 330
container_title Immunopharmacology and immunotoxicology
container_volume 42
creator Berköz, Mehmet
Krośniak, Mirosław
Özkan-Yılmaz, Ferbal
Özlüer-Hunt, Arzu
description Aim/Purpose of the study:Inhibition of microglial activation using phytochemicals may be a potential candidate for the prevention of neurodegenerative diseases caused by neuroinflammation and oxidative stress. The goal of this study was to investigate the protective role of Biochanin A on lipopolysaccharide (LPS)-stimulated BV2 microglial cells. BV2 microglial cells were treated with LPS in the presence and absence of Biochanin A. Materials and methods: For this aim, nitric oxide production, nuclear factor kappa B (NF-κB), tumor necrosis factor alpha (TNF-α), interleukin-1 beta (IL-1β), IL-6, Prostaglandin E2 (PGE2), and reactive oxygen species (ROS) levels, inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2), myeloid differentiation factor-88 (MyD88), and toll like receptor-4 (TLR-4) protein expressions, Akt and ERK1/2 phosphorylation levels were measured. Results:Biochanin A pretreatment resulted in significant and concentration-dependently reduced the LPS-induced production of nitric oxide, NF-κB p65, TNF-α, IL-1β, IL-6, PGE2, and ROS compared to the untreated group. Biochanin A prophylaxis exerted an anti-inflammatory effect by suppressing iNOS, COX-2, MyD88, and TLR-4 protein expressions and Akt and ERK1/2 pathway activation. Conclusion:Taken together, these results show that Biochanin A exerts antioxidant and anti-inflammatory activities, thus may be beneficial for preventing neurodegenerative diseases mediated by microglial cells.
doi_str_mv 10.1080/08923973.2020.1769128
format article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1080_08923973_2020_1769128</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>32482108</sourcerecordid><originalsourceid>FETCH-LOGICAL-c366t-2da095b8c43379e31612d9aeb7337a5f7568c6dcc5c2a9301ee5fb9b052450f3</originalsourceid><addsrcrecordid>eNp9kF9LwzAUxYMobk4_gpIv0Jk_S9u8uQ3_wUAfhvgW0jRxkbQpSYf025uyzUdf7uUezrkHfgDcYjTHqET3qOSE8oLOCSJJKnKOSXkGpphRkhGG6TmYjp5sNE3AVYzfCGFeIHYJJpQsSpLeTMHne_DdbnBS9VZBbYxWPfQGrqxXO9naFi5hGs52vvNuiFIlOdhaZ7G3zd7JXtdw9UFgY1XwX85KB5V2Ll6DCyNd1DfHPQPbp8ft-iXbvD2_rpebTNE87zNSS8RZVaoFpQXXFOeY1Fzqqki3ZKZgeanyWimmiOQUYa2ZqXiFGFkwZOgMsMPb1B5j0EZ0wTYyDAIjMYISJ1BiBCWOoFLu7pDr9lWj67_UiUwyPBwMtjU-NPLHB1eLXg7OBxNkq2wU9P-OXwf_eDc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Prophylactic effect of Biochanin A in lipopolysaccharide-stimulated BV2 microglial cells</title><source>Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list)</source><creator>Berköz, Mehmet ; Krośniak, Mirosław ; Özkan-Yılmaz, Ferbal ; Özlüer-Hunt, Arzu</creator><creatorcontrib>Berköz, Mehmet ; Krośniak, Mirosław ; Özkan-Yılmaz, Ferbal ; Özlüer-Hunt, Arzu</creatorcontrib><description>Aim/Purpose of the study:Inhibition of microglial activation using phytochemicals may be a potential candidate for the prevention of neurodegenerative diseases caused by neuroinflammation and oxidative stress. The goal of this study was to investigate the protective role of Biochanin A on lipopolysaccharide (LPS)-stimulated BV2 microglial cells. BV2 microglial cells were treated with LPS in the presence and absence of Biochanin A. Materials and methods: For this aim, nitric oxide production, nuclear factor kappa B (NF-κB), tumor necrosis factor alpha (TNF-α), interleukin-1 beta (IL-1β), IL-6, Prostaglandin E2 (PGE2), and reactive oxygen species (ROS) levels, inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2), myeloid differentiation factor-88 (MyD88), and toll like receptor-4 (TLR-4) protein expressions, Akt and ERK1/2 phosphorylation levels were measured. Results:Biochanin A pretreatment resulted in significant and concentration-dependently reduced the LPS-induced production of nitric oxide, NF-κB p65, TNF-α, IL-1β, IL-6, PGE2, and ROS compared to the untreated group. Biochanin A prophylaxis exerted an anti-inflammatory effect by suppressing iNOS, COX-2, MyD88, and TLR-4 protein expressions and Akt and ERK1/2 pathway activation. Conclusion:Taken together, these results show that Biochanin A exerts antioxidant and anti-inflammatory activities, thus may be beneficial for preventing neurodegenerative diseases mediated by microglial cells.</description><identifier>ISSN: 0892-3973</identifier><identifier>EISSN: 1532-2513</identifier><identifier>DOI: 10.1080/08923973.2020.1769128</identifier><identifier>PMID: 32482108</identifier><language>eng</language><publisher>England: Taylor &amp; Francis</publisher><subject>Animals ; Anticarcinogenic Agents - administration &amp; dosage ; Biochanin A ; BV2 microglial cells ; Cell Line ; Cell Survival - drug effects ; Cell Survival - physiology ; Dose-Response Relationship, Drug ; Genistein - administration &amp; dosage ; Lipopolysaccharides - toxicity ; Mice ; Microglia - drug effects ; Microglia - metabolism ; neuroinflammation ; nuclear factor kappa B ; Pre-Exposure Prophylaxis - methods ; Reactive Oxygen Species - antagonists &amp; inhibitors ; Reactive Oxygen Species - metabolism ; reactive-oxygen species</subject><ispartof>Immunopharmacology and immunotoxicology, 2020-07, Vol.42 (4), p.330-339</ispartof><rights>2020 Informa UK Limited, trading as Taylor &amp; Francis Group 2020</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c366t-2da095b8c43379e31612d9aeb7337a5f7568c6dcc5c2a9301ee5fb9b052450f3</citedby><cites>FETCH-LOGICAL-c366t-2da095b8c43379e31612d9aeb7337a5f7568c6dcc5c2a9301ee5fb9b052450f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32482108$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Berköz, Mehmet</creatorcontrib><creatorcontrib>Krośniak, Mirosław</creatorcontrib><creatorcontrib>Özkan-Yılmaz, Ferbal</creatorcontrib><creatorcontrib>Özlüer-Hunt, Arzu</creatorcontrib><title>Prophylactic effect of Biochanin A in lipopolysaccharide-stimulated BV2 microglial cells</title><title>Immunopharmacology and immunotoxicology</title><addtitle>Immunopharmacol Immunotoxicol</addtitle><description>Aim/Purpose of the study:Inhibition of microglial activation using phytochemicals may be a potential candidate for the prevention of neurodegenerative diseases caused by neuroinflammation and oxidative stress. The goal of this study was to investigate the protective role of Biochanin A on lipopolysaccharide (LPS)-stimulated BV2 microglial cells. BV2 microglial cells were treated with LPS in the presence and absence of Biochanin A. Materials and methods: For this aim, nitric oxide production, nuclear factor kappa B (NF-κB), tumor necrosis factor alpha (TNF-α), interleukin-1 beta (IL-1β), IL-6, Prostaglandin E2 (PGE2), and reactive oxygen species (ROS) levels, inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2), myeloid differentiation factor-88 (MyD88), and toll like receptor-4 (TLR-4) protein expressions, Akt and ERK1/2 phosphorylation levels were measured. Results:Biochanin A pretreatment resulted in significant and concentration-dependently reduced the LPS-induced production of nitric oxide, NF-κB p65, TNF-α, IL-1β, IL-6, PGE2, and ROS compared to the untreated group. Biochanin A prophylaxis exerted an anti-inflammatory effect by suppressing iNOS, COX-2, MyD88, and TLR-4 protein expressions and Akt and ERK1/2 pathway activation. Conclusion:Taken together, these results show that Biochanin A exerts antioxidant and anti-inflammatory activities, thus may be beneficial for preventing neurodegenerative diseases mediated by microglial cells.</description><subject>Animals</subject><subject>Anticarcinogenic Agents - administration &amp; dosage</subject><subject>Biochanin A</subject><subject>BV2 microglial cells</subject><subject>Cell Line</subject><subject>Cell Survival - drug effects</subject><subject>Cell Survival - physiology</subject><subject>Dose-Response Relationship, Drug</subject><subject>Genistein - administration &amp; dosage</subject><subject>Lipopolysaccharides - toxicity</subject><subject>Mice</subject><subject>Microglia - drug effects</subject><subject>Microglia - metabolism</subject><subject>neuroinflammation</subject><subject>nuclear factor kappa B</subject><subject>Pre-Exposure Prophylaxis - methods</subject><subject>Reactive Oxygen Species - antagonists &amp; inhibitors</subject><subject>Reactive Oxygen Species - metabolism</subject><subject>reactive-oxygen species</subject><issn>0892-3973</issn><issn>1532-2513</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp9kF9LwzAUxYMobk4_gpIv0Jk_S9u8uQ3_wUAfhvgW0jRxkbQpSYf025uyzUdf7uUezrkHfgDcYjTHqET3qOSE8oLOCSJJKnKOSXkGpphRkhGG6TmYjp5sNE3AVYzfCGFeIHYJJpQsSpLeTMHne_DdbnBS9VZBbYxWPfQGrqxXO9naFi5hGs52vvNuiFIlOdhaZ7G3zd7JXtdw9UFgY1XwX85KB5V2Ll6DCyNd1DfHPQPbp8ft-iXbvD2_rpebTNE87zNSS8RZVaoFpQXXFOeY1Fzqqki3ZKZgeanyWimmiOQUYa2ZqXiFGFkwZOgMsMPb1B5j0EZ0wTYyDAIjMYISJ1BiBCWOoFLu7pDr9lWj67_UiUwyPBwMtjU-NPLHB1eLXg7OBxNkq2wU9P-OXwf_eDc</recordid><startdate>20200715</startdate><enddate>20200715</enddate><creator>Berköz, Mehmet</creator><creator>Krośniak, Mirosław</creator><creator>Özkan-Yılmaz, Ferbal</creator><creator>Özlüer-Hunt, Arzu</creator><general>Taylor &amp; Francis</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20200715</creationdate><title>Prophylactic effect of Biochanin A in lipopolysaccharide-stimulated BV2 microglial cells</title><author>Berköz, Mehmet ; Krośniak, Mirosław ; Özkan-Yılmaz, Ferbal ; Özlüer-Hunt, Arzu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c366t-2da095b8c43379e31612d9aeb7337a5f7568c6dcc5c2a9301ee5fb9b052450f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Animals</topic><topic>Anticarcinogenic Agents - administration &amp; dosage</topic><topic>Biochanin A</topic><topic>BV2 microglial cells</topic><topic>Cell Line</topic><topic>Cell Survival - drug effects</topic><topic>Cell Survival - physiology</topic><topic>Dose-Response Relationship, Drug</topic><topic>Genistein - administration &amp; dosage</topic><topic>Lipopolysaccharides - toxicity</topic><topic>Mice</topic><topic>Microglia - drug effects</topic><topic>Microglia - metabolism</topic><topic>neuroinflammation</topic><topic>nuclear factor kappa B</topic><topic>Pre-Exposure Prophylaxis - methods</topic><topic>Reactive Oxygen Species - antagonists &amp; inhibitors</topic><topic>Reactive Oxygen Species - metabolism</topic><topic>reactive-oxygen species</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Berköz, Mehmet</creatorcontrib><creatorcontrib>Krośniak, Mirosław</creatorcontrib><creatorcontrib>Özkan-Yılmaz, Ferbal</creatorcontrib><creatorcontrib>Özlüer-Hunt, Arzu</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Immunopharmacology and immunotoxicology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Berköz, Mehmet</au><au>Krośniak, Mirosław</au><au>Özkan-Yılmaz, Ferbal</au><au>Özlüer-Hunt, Arzu</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prophylactic effect of Biochanin A in lipopolysaccharide-stimulated BV2 microglial cells</atitle><jtitle>Immunopharmacology and immunotoxicology</jtitle><addtitle>Immunopharmacol Immunotoxicol</addtitle><date>2020-07-15</date><risdate>2020</risdate><volume>42</volume><issue>4</issue><spage>330</spage><epage>339</epage><pages>330-339</pages><issn>0892-3973</issn><eissn>1532-2513</eissn><abstract>Aim/Purpose of the study:Inhibition of microglial activation using phytochemicals may be a potential candidate for the prevention of neurodegenerative diseases caused by neuroinflammation and oxidative stress. The goal of this study was to investigate the protective role of Biochanin A on lipopolysaccharide (LPS)-stimulated BV2 microglial cells. BV2 microglial cells were treated with LPS in the presence and absence of Biochanin A. Materials and methods: For this aim, nitric oxide production, nuclear factor kappa B (NF-κB), tumor necrosis factor alpha (TNF-α), interleukin-1 beta (IL-1β), IL-6, Prostaglandin E2 (PGE2), and reactive oxygen species (ROS) levels, inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2), myeloid differentiation factor-88 (MyD88), and toll like receptor-4 (TLR-4) protein expressions, Akt and ERK1/2 phosphorylation levels were measured. Results:Biochanin A pretreatment resulted in significant and concentration-dependently reduced the LPS-induced production of nitric oxide, NF-κB p65, TNF-α, IL-1β, IL-6, PGE2, and ROS compared to the untreated group. Biochanin A prophylaxis exerted an anti-inflammatory effect by suppressing iNOS, COX-2, MyD88, and TLR-4 protein expressions and Akt and ERK1/2 pathway activation. Conclusion:Taken together, these results show that Biochanin A exerts antioxidant and anti-inflammatory activities, thus may be beneficial for preventing neurodegenerative diseases mediated by microglial cells.</abstract><cop>England</cop><pub>Taylor &amp; Francis</pub><pmid>32482108</pmid><doi>10.1080/08923973.2020.1769128</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0892-3973
ispartof Immunopharmacology and immunotoxicology, 2020-07, Vol.42 (4), p.330-339
issn 0892-3973
1532-2513
language eng
recordid cdi_crossref_primary_10_1080_08923973_2020_1769128
source Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list)
subjects Animals
Anticarcinogenic Agents - administration & dosage
Biochanin A
BV2 microglial cells
Cell Line
Cell Survival - drug effects
Cell Survival - physiology
Dose-Response Relationship, Drug
Genistein - administration & dosage
Lipopolysaccharides - toxicity
Mice
Microglia - drug effects
Microglia - metabolism
neuroinflammation
nuclear factor kappa B
Pre-Exposure Prophylaxis - methods
Reactive Oxygen Species - antagonists & inhibitors
Reactive Oxygen Species - metabolism
reactive-oxygen species
title Prophylactic effect of Biochanin A in lipopolysaccharide-stimulated BV2 microglial cells
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T18%3A19%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prophylactic%20effect%20of%20Biochanin%20A%20in%20lipopolysaccharide-stimulated%20BV2%20microglial%20cells&rft.jtitle=Immunopharmacology%20and%20immunotoxicology&rft.au=Berk%C3%B6z,%20Mehmet&rft.date=2020-07-15&rft.volume=42&rft.issue=4&rft.spage=330&rft.epage=339&rft.pages=330-339&rft.issn=0892-3973&rft.eissn=1532-2513&rft_id=info:doi/10.1080/08923973.2020.1769128&rft_dat=%3Cpubmed_cross%3E32482108%3C/pubmed_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c366t-2da095b8c43379e31612d9aeb7337a5f7568c6dcc5c2a9301ee5fb9b052450f3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/32482108&rfr_iscdi=true